Triple
T23431829
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Regulation (EC) No 1901/2006 |
E563353
|
entity |
| Predicate | officialName |
P66
|
FINISHED |
| Object | Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use | Statement: [Regulation (EC) No 1901/2006, officialName, Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use Context triple: [Regulation (EC) No 1901/2006, officialName, Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use]
-
A.
Regulation (EC) No 141/2000 on orphan medicinal products
Regulation (EC) No 141/2000 on orphan medicinal products is a key European Union law that establishes incentives and a special approval framework to encourage the development and marketing of medicines for rare diseases.
-
B.
Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products
Directive 2001/82/EC is a key piece of European Union legislation that harmonizes the rules for the authorization, manufacture, distribution, and pharmacovigilance of veterinary medicinal products across EU member states.
-
C.
Regulation (EC) No 1901/2006
chosen
Regulation (EC) No 1901/2006 is the European Union’s Paediatric Regulation, establishing rules to ensure that medicines for children are researched, developed, and authorized to the same high standards as those for adults.
-
D.
Council Regulation (EC) No 510/2006
Council Regulation (EC) No 510/2006 was an EU law establishing the system for protecting geographical indications and designations of origin for agricultural products and foodstuffs before being replaced by Regulation (EU) No 1151/2012.
-
E.
Regulation (EC) No 726/2004
Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e24553980c8190bb66a2ae0bdab125 |
completed | April 17, 2026, 2:36 p.m. |
| NER | Named-entity recognition | batch_69f1a5d920548190904f80c7c40cba06 |
completed | April 29, 2026, 6:31 a.m. |
Created at: April 17, 2026, 5:49 p.m.